Facebook Linkedin RSS Twitter Youtube
Home 2024

Clinical trial

Bridgebio’s Attruby, to Treat Heart Condition ATTR-CM, Receives FDA Approval
Drug Discovery

Bridgebio’s Attruby, to Treat Heart Condition ATTR-CM, Receives FDA Approval

Xiaorong He on Boehringer Ingelheim’s Investments in AI, Broader Applications in Pharma
Artificial Intelligence

Xiaorong He on Boehringer Ingelheim’s Investments in AI, Broader Applications in Pharma

Aggressive Tumor Growth in Drug-Resistant Prostate Cancer Driven by Enzyme
Cancer

Aggressive Tumor Growth in Drug-Resistant Prostate Cancer Driven by Enzyme

Asimov and RevOpsis Therapeutics Ink Licensing Deal for Multispecific-Expressing Cell Line
Bioprocessing

Asimov and RevOpsis Therapeutics Ink Licensing Deal for Multispecific-Expressing Cell Line

CAR T-Cells Use SNIPR Technology to Confirm Cancer Targets before Firing
Cancer

CAR T-Cells Use SNIPR Technology to Confirm Cancer Targets before Firing

CAR T-Cell Therapy Shows Efficacy in Young Patients with Incurable Brain Cancer
Cancer

CAR T-Cell Therapy Shows Efficacy in Young Patients with Incurable Brain Cancer

Insilico Plans Pivotal Trial for AI-Based IPF Candidate
Artificial Intelligence

Insilico Plans Pivotal Trial for AI-Based IPF Candidate

Patient Dies in Beam Trial of SCD Candidate; Company Cites Conditioning
GEN Edge

Patient Dies in Beam Trial of SCD Candidate; Company Cites Conditioning

Alzheimer’s Drug Shows Slower Cognitive Decline in Lower Tau Patients
Drug Discovery

Alzheimer’s Drug Shows Slower Cognitive Decline in Lower Tau Patients

Synaffix Collaborates with BigHat Biosciences on the Development of Machine Learning-Designed ADC
Bioprocessing

Synaffix Collaborates with BigHat Biosciences on the Development of Machine Learning-Designed ADC

123...274Page 2 of 274
Copyright © 2025 Genetic Engineering & Biotechnology News. All Rights Reserved.